Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that the Department of Veterans Affairs' Federal Supply Schedule Service has accepted CTT's application to be an approved vendor for its Calmare® Pain Therapy Treatment. This decision will enable CTT to sell Calmare Pain Therapy to physicians throughout the Federal government, with the expectation of significant sales in that market sector, which includes the Department of Veterans Affairs, the Department of Defense, the Indian Health Service, the Bureau of Prisons, and State Veteran Homes.
"This approval by the Federal government will place our Calmare Pain Therapy Treatment on the Federal Supply Schedule, enabling physicians in the VA and DoD healthcare systems to purchase Calmare devices to treat our many veterans and wounded warriors who are suffering from debilitating pain every day," said John B. Nano, CTT's Chairman, President and CEO. "With as many as 60% of our returning war veterans suffering from significant pain, we are grateful to be able to offer these wounded warriors and their physicians a non-invasive pain relief option without the harmful, adverse side effects associated with powerful opioids, such as morphine."